ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
ICON offers the knowledge, software, systems and global footprint to make global adaptive trials a reality.
ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – IIIb trials.
ICON Consulting Services provides strategic analysis to support improved decision-making in drug and device development.
ICON provides expertise to accelerate market access and drive product adoption.
ICON experts can help to implement patient-centric, alternative trial models - from the integration of digital health technologies to in-home clinical visits and agile monitoring solutions.
ICON specialises in the strategy and delivery of early phase clinical development.
ICON provides laboratory services through our global Central Laboratories, Bioanalytical Laboratory and Specialty Laboratories.
ICON is the industry's largest life sciences language services provider.
ICON provides medical imaging based product development services that expedite drug development.
ICON optimises real world data use to drive effective outcomes and achieve regulatory authorisation
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON is redefining FSP to provide sponsors with flexibility to meet the demands of modern drug development.